Rapid-Onset Subacute Combined Degeneration After Short-Term, High-Dose Nitrous Oxide Use.
Jacob Michalik, Neal Madhani
✦ AI-curated · Sources linked
Case in brief
The title identifies a case of rapid-onset subacute combined degeneration (SCD) after short-term, high-dose recreational nitrous oxide use. The abstract explains that nitrous oxide can functionally inhibit cobalamin-dependent methionine synthase, disrupting pathways involved in myelin maintenance. Serum vitamin B12 may remain normal despite this functional deficiency; homocysteine and methylmalonic acid can help confirm it. SCD typically affects the dorsal columns and may also involve corticospinal tracts. The abstract does not provide patient-specific examination findings, test results, treatment details, or outcome.
What made this case unusual
The reported diagnostic teaching point is that brief, high-dose nitrous oxide exposure can be associated with rapid neurologic decline and SCD, despite the condition’s usual association with chronic exposure.
Diagnostic / clinical pearl
In suspected nitrous oxide–related SCD, a normal serum vitamin B12 level does not exclude functional deficiency; homocysteine and methylmalonic acid may help establish the diagnosis.
Why it matters
The abstract notes that early recognition and prompt parenteral vitamin B12 replacement may reduce the risk of irreversible neurologic deficits.